Burgundy Asset Management LTD Has Raised Holding in Premier (PINC) by $396,288; As Loxo Oncology (LOXO) Stock Rose, Holder Driehaus Capital Management Upped Holding

January 14, 2018 - By Dolores Ford

Burgundy Asset Management Ltd increased its stake in Premier Inc. (PINC) by 3.91% based on its latest 2017Q3 regulatory filing with the SEC. Burgundy Asset Management Ltd bought 12,384 shares as the company’s stock rose 10.37% with the market. The institutional investor held 328,984 shares of the consumer services company at the end of 2017Q3, valued at $10.72 million, up from 316,600 at the end of the previous reported quarter. Burgundy Asset Management Ltd who had been investing in Premier Inc. for a number of months, seems to be bullish on the $4.44B market cap company. The stock increased 1.79% or $0.56 during the last trading session, reaching $31.82. About 711,480 shares traded. Premier, Inc. (NASDAQ:PINC) has risen 13.15% since January 14, 2017 and is uptrending. It has underperformed by 3.55% the S&P500.

Richard Driehaus increased its stake in Loxo Oncology Inc (LOXO) by 14.51% based on its latest 2017Q3 regulatory filing with the SEC. Driehaus Capital Management Llc bought 51,895 shares as the company’s stock rose 10.54% with the market. The hedge fund run by Richard Driehaus held 409,536 shares of the health care company at the end of 2017Q3, valued at $37.73 million, up from 357,641 at the end of the previous reported quarter. Driehaus Capital Management Llc who had been investing in Loxo Oncology Inc for a number of months, seems to be bullish on the $2.69 billion market cap company. The stock increased 1.27% or $1.13 during the last trading session, reaching $89.99. About 440,691 shares traded. Loxo Oncology, Inc. (NASDAQ:LOXO) has risen 77.12% since January 14, 2017 and is uptrending. It has outperformed by 60.42% the S&P500.

Since August 15, 2017, it had 0 insider purchases, and 4 sales for $2.58 million activity. On Tuesday, August 15 the insider McKasson Craig S. sold $360,663. Shares for $1.31 million were sold by DeVore Susan D.. Anderson Leigh had sold 2,264 shares worth $74,101.

Investors sentiment increased to 1.72 in 2017 Q3. Its up 0.20, from 1.52 in 2017Q2. It increased, as 23 investors sold PINC shares while 41 reduced holdings. 30 funds opened positions while 80 raised stakes. 52.07 million shares or 2.52% more from 50.79 million shares in 2017Q2 were reported. Timessquare Cap Limited Com holds 0.59% of its portfolio in Premier, Inc. (NASDAQ:PINC) for 2.72 million shares. Nuveen Asset Limited Liability Company holds 43,534 shares or 0.01% of its portfolio. Segall Bryant Hamill Limited Co reported 104,043 shares stake. Prelude Mgmt Limited Liability Corporation has 2,300 shares. Schwab Charles Management reported 181,877 shares. Federated Pa has invested 0% in Premier, Inc. (NASDAQ:PINC). Citigroup holds 954 shares or 0% of its portfolio. Ahl Llp, a United Kingdom-based fund reported 303,708 shares. Stevens Mgmt Limited Partnership accumulated 9,601 shares or 0.01% of the stock. Advsrs Asset Mgmt has 0% invested in Premier, Inc. (NASDAQ:PINC) for 3,364 shares. Suntrust Banks invested in 49,831 shares or 0.01% of the stock. Magnetar Financial Limited invested 0.03% in Premier, Inc. (NASDAQ:PINC). Patten Grp Inc, a Tennessee-based fund reported 7,155 shares. 34,415 are held by Paloma Ptnrs Mngmt. Pzena Inv Mgmt Ltd Liability Corporation invested in 0% or 10,508 shares.

Among 17 analysts covering Premier (NASDAQ:PINC), 10 have Buy rating, 1 Sell and 6 Hold. Therefore 59% are positive. Premier had 37 analyst reports since August 25, 2015 according to SRatingsIntel. On Tuesday, August 25 the stock rating was maintained by Canaccord Genuity with “Buy”. As per Wednesday, October 7, the company rating was maintained by JP Morgan. The stock has “Buy” rating by Robert W. Baird on Tuesday, August 22. The stock has “Buy” rating by Robert W. Baird on Wednesday, January 10. On Tuesday, October 24 the stock rating was downgraded by KeyBanc Capital Markets to “Sector Weight”. The rating was maintained by Topeka Capital Markets with “Buy” on Tuesday, August 25. On Friday, August 5 the stock rating was initiated by Credit Suisse with “Outperform”. On Tuesday, December 19 the stock rating was downgraded by J.P. Morgan to “Hold”. The stock has “Outperform” rating by Oppenheimer on Wednesday, October 7. The stock of Premier, Inc. (NASDAQ:PINC) has “Buy” rating given on Tuesday, October 3 by SunTrust.

Burgundy Asset Management Ltd, which manages about $19.85 billion and $10.56 billion US Long portfolio, decreased its stake in Booz Allen Hamilton Holding Corp. (NYSE:BAH) by 714,707 shares to 1.44 million shares, valued at $53.79 million in 2017Q3, according to the filing. It also reduced its holding in Tempur Sealy Intly Inc. (NYSE:TPX) by 124,159 shares in the quarter, leaving it with 931,364 shares, and cut its stake in Royal Bank Of Canada (NYSE:RY).

Since August 14, 2017, it had 0 insider buys, and 17 selling transactions for $68.83 million activity. Van Naarden Jacob sold $274,289 worth of Loxo Oncology, Inc. (NASDAQ:LOXO) on Monday, September 18. ORBIMED ADVISORS LLC had sold 250,000 shares worth $20.63 million. Shares for $1.22 million were sold by Bilenker Joshua H.. Another trade for 1,700 shares valued at $125,347 was sold by Burstein Jennifer. Naider Avi Z. sold 5,000 shares worth $450,000. Kunkel Lori Anne had sold 10,000 shares worth $751,731 on Tuesday, August 22.

Among 10 analysts covering Loxo Oncology Inc (NASDAQ:LOXO), 9 have Buy rating, 1 Sell and 0 Hold. Therefore 90% are positive. Loxo Oncology Inc had 30 analyst reports since July 29, 2015 according to SRatingsIntel. Citigroup upgraded Loxo Oncology, Inc. (NASDAQ:LOXO) on Monday, June 5 to “Buy” rating. Morgan Stanley maintained Loxo Oncology, Inc. (NASDAQ:LOXO) on Monday, June 19 with “Buy” rating. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) has “Buy” rating given on Friday, January 15 by Citigroup. The company was maintained on Monday, June 5 by BTIG Research. On Friday, October 20 the stock rating was maintained by Citigroup with “Buy”. The rating was upgraded by IFS Securities on Tuesday, November 14 to “Strong Buy”. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) has “Buy” rating given on Monday, June 5 by Cowen & Co. The firm has “Buy” rating given on Thursday, November 2 by Stifel Nicolaus. The stock has “Buy” rating by Citigroup on Monday, January 18. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) earned “Buy” rating by Stifel Nicolaus on Tuesday, August 8.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>